POCKETSPPI · Discovering and exploiting hidden pockets at protein-protein interfaces
7РП — „Хора“ (Действия „Мария Кюри“)
- Период
- 2011-09-01 → 2015-08-31
- Финансиране от ЕС
- 100 000 €
- Участници
- 1
- Схема
- MC-IRG
Линиите свързват координатора с партньорите.
Накратко на български
Протеиновите интерфейси се анализират чрез компютърни модели, за да се открият скрити „джобове“, в които могат да се свържат малки молекули. Това помага за разработването на нови лекарства, които да взаимодействат по-ефективно с конкретни протеини в организма.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Discovering and exploiting hidden pockets at protein-protein interfaces
The objectives of this project were to develop, validate and apply new computational methodologies that, starting from a protein structure solved by experimental methods, identify and characterize alternative conformational states that are deemed more “druggable” by small molecules. In selected cases, predictions from computational modelling were married with in vitro experiments in collaboration with other research groups. Diverse sub-goals were set and completed during the project. In the first aim of the work, initial efforts were focussed on the elucidation of the mechanisms of small molecule binding to the intrinsically disordered protein c-Myc. Our simulation studies have ruled out the presence of stable hidden pockets in this target protein and suggest instead that current inhibitors bind to this target protein through weak, non-specific interactions. Additional work used molecular dynamics simulations to detect transient conformations that are ‘’druggable’’ by small molecule. This has led to the development of the JEDI algorithm to predict the druggability of a protein structure. A unique aspect of the JEDI approach is that the druggability descriptor is fully compatible with ‘’on the fly’’ molecular dynamics simulations. This enables us to perform biased molecular dynamics simulations to steer protein conformations towards a priori-unknown, yet druggable, conformational states. Promising results have been obtained and published in leading chemistry journals, and work on further developments of the JEDI tool continues beyond the funding period of this project. We have also initiated a collaborative computational/experimental effort to characterise the binding of macrocyclic ligands and small fragments to selected cyclophilin proteins. Molecular simulations, X-ray analyses and in vitro assays have identified fragments that bind weakly to different regions of diverse cyclophilin proteins and via distinct molecular recognition mechanisms. The results of this work have not yet been published, by funding has been secured to develop further the results via follow-up experiments aimed at improving binding affinity and selectivity of the cyclophilin fragments. Overall the primary outputs of the project were: 1) improved computational methods to guide the rational structure-based design of protein ligands; 2) new insights into biomolecular recognition.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Protein-protein interactions play critical roles in normal human physiology, as well as in numerous diseases such as cancers and neurodegenerative disorders. However, identifying small molecule drugs to block protein interactions is a very difficult task. One of the major difficulties is that often the proteins involved are extremely flexible and readily change shape, which greatly complicates efforts to find small molecule ligands of matching shape. In this project, we aim to exploit protein flexibility to create new opportunities for drug discovery.Interactions between a given pair of proteins commonly requires one or both partners to transiently form pockets that allow selective binding. Therefore, most protein interfaces likely possess many more binding pockets than those apparent in the static picture of a protein structure revealed by crystallographic experiments. We propose to identify these ""hidden"" pockets using computational methods. Thus, we will develop and validate molecular simulation methodologies to detect hidden pockets at protein interfaces and assess their small molecule ""druggability"" using docking calculations and binding site scoring functions. Such capacity would greatly strengthen the reliability of in silico drug design. We will perform virtual screens to find small molecule ligands binding to hidden pockets in medicinally important proteins such as FcgammaRIIA or PCNA. Finally, we will purchase or synthesize promising ligands and assay their activity against protein targets. These studies will allow us to test the utility of our computational approach in rational drug design.The objectives of this research are part of a broader program we are currently developing and whose purpose is to provide a comprehensive set of computational/biophysical methods to allow the widespread targeting of seemingly ""undruggable"" protein families with small molecules, thereby expanding the scope of modern molecular medicine.""
Оригинален текст от CORDIS (на английски).
Участници
- THE UNIVERSITY OF EDINBURGH · EdinburghКоординаторОбединеното кралство
Връзки
Данни: CORDIS, © Европейски съюз
